Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Reno, NV, June 03, 2026 (GLOBE NEWSWIRE) -- M2i Global, Inc. (“M2i,” the “Company,” “we,” “our” or “us”) (OTCQB: MTWO), a company specializing in the development and execution of a complete global...
-
BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping...
-
CONSHOHOCKEN, Pa., June 03, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 47th Annual Global Goldman Sachs Health...
-
ZUG, Switzerland, June 03, 2026 (GLOBE NEWSWIRE) -- Xcubebio AG, a market entry acceleration engine for innovative biopharma and transformative therapeutics, today announced the appointments of...
-
One of the largest deployments of agentic AI in audit and advisory to date, signaling a shift from point tools to platform-driven operating models across the profession SAN FRANCISCO, June 03, 2026 ...
-
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- AlphaSense, the AI platform redefining market intelligence for the business and financial world, today announced the close of a $350 million funding round...
-
CAMBRIDGE, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
-
WALTHAM, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
-
RADNOR, Pa., June 03, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related...
-
Transaction in Own Shares 02 June, 2026 • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 02 June, 2026 it purchased the following number of Shares for cancellation. ...